Patellofemoral arthroplasty (PFA) prosthesis with asymmetric trochlear component was introduced as an improvement from existing designs for surgical treatment of symptomatic isolated patellofemoral arthritis. The purpose of this study was to evaluate midterm results in patients who underwent PFA procedure using such prosthesis.
Our study involved a continuous retrospective cohort of patients who underwent PFA using Journey PFA prosthesis with an asymmetric trochlear component, performed between June 2007 and July 2016 at a non-designer centre. The Patient Reported Outcome Measures and patient satisfaction questionnaires were collected for final evaluation.
A total of 103 PFA performed on 79 patients were evaluated. Median age at the time of surgery was 58years (range 42 to 78years); the mean follow-up period was 6 years (range 2 to 11years). Four knees were revised to Total Knee Arthroplasty for reasons not related to the implant. The cumulative survival estimated by the Kaplan-Meier method was 94.3% (95% confidence interval: 88.4%-100%). There were statistically significant improvements in functional outcome scores.
This series of patients who underwent PFA with the asymmetric trochlear component has shown promising mid-term results with no implant-related complications.